Rajthanee Hospital Public Company Limited Stocks

THB 12.3Last Updated 27.04.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

THB 110.56M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
THB 12.3
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Rajthanee Hospital Public Company Limited, together with its subsidiaries, provides healthcare services in Thailand. The company offers medical, health improvement, rehabilitation, and medical prevention services for general and acute illness through general practice and specialty physicians. It also provides medical services in areas, such as medicine, surgery and orthopedics, pediatrics, obstetrics and gynecology, otolaryngology, ophthalmology, anesthesiology, radiology, and dentistry. The company operates emergency medicine and brain neurosurgery, heart, surgery, orthopedics, health check-up, radiology, diagnostic, ophthalmology, hemodialysis, sleep test, and dental centers. Rajthanee Hospital Public Company Limited was incorporated in 1990 and is headquartered in Phra Nakhon Si Ayutthaya, Thailand.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, reasonably pr

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of RJH.BK is 14 and suggests 10% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks